Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuemeng Liu

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Materials Today. Bio|January 21, 2026
Co-delivery of panobinostat and siSTAT3 using engineered M1 exosomes to establish a one-two punch therapeutic strategy for glioblastoma recurrenceXuemeng Liu, Yaotian Hu, Yan Zhang, et al.
Frontiers in Endocrinology|May 11, 2026
Correction: Shared immune-inflammatory gene networks and drug prediction in polycystic ovary syndrome and type 2 diabetes mellitus: a bioinformatics and experimental validation studyXuemeng Liu, Yanlei Wang, Qiuhan Bi, et al.
JMIR Public Health and Surveillance|February 21, 2025
Association Among BMI, Self-Esteem, and Nonsuicidal Self-Injury in Young Adults to Understand the Influence of Socioenvironmental Factors: Longitudinal StudyYi Zhang, Ruixue Ying, Wan Lu, et al.
Frontiers in Endocrinology|May 11, 2026
Shared immune-inflammatory gene networks and drug prediction in polycystic ovary syndrome and type 2 diabetes mellitus: a bioinformatics and experimental validation studyXuemeng Liu, Yanlei Wang, Qiuhan Bi, et al.
Frontiers in Oncology|September 22, 2023
Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM)Xiaobing Yang, Di Lu, Yanfei Sun, et al.
Orphanet Journal of Rare Diseases|December 2, 2024
Clinical spectrum and molecular basis in 19 Chinese patients with 46, XY disorder of sexual development caused by NR5A1 mutationsYue Xu, Xuemeng Liu, Yang Liu, et al.
Neuro-Oncology|December 9, 2023
Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastomaYanfei Sun, Guangjing Mu, Xuehai Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 21, 2024
The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactionsZhiyi Xue, Yan Zhang, Ruiqi Zhao, et al.
Physical Review Letters|March 25, 2025
Establishing a New Benchmark in Quantum Computational Advantage with 105-qubit Zuchongzhi 3.0 ProcessorDongxin Gao, Daojin Fan, Chen Zha, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Materials Today. Bio|January 21, 2026
Co-delivery of panobinostat and siSTAT3 using engineered M1 exosomes to establish a one-two punch therapeutic strategy for glioblastoma recurrenceXuemeng Liu, Yaotian Hu, Yan Zhang, et al.
Frontiers in Endocrinology|May 11, 2026
Correction: Shared immune-inflammatory gene networks and drug prediction in polycystic ovary syndrome and type 2 diabetes mellitus: a bioinformatics and experimental validation studyXuemeng Liu, Yanlei Wang, Qiuhan Bi, et al.
JMIR Public Health and Surveillance|February 21, 2025
Association Among BMI, Self-Esteem, and Nonsuicidal Self-Injury in Young Adults to Understand the Influence of Socioenvironmental Factors: Longitudinal StudyYi Zhang, Ruixue Ying, Wan Lu, et al.
Frontiers in Endocrinology|May 11, 2026
Shared immune-inflammatory gene networks and drug prediction in polycystic ovary syndrome and type 2 diabetes mellitus: a bioinformatics and experimental validation studyXuemeng Liu, Yanlei Wang, Qiuhan Bi, et al.
Frontiers in Oncology|September 22, 2023
Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM)Xiaobing Yang, Di Lu, Yanfei Sun, et al.
Orphanet Journal of Rare Diseases|December 2, 2024
Clinical spectrum and molecular basis in 19 Chinese patients with 46, XY disorder of sexual development caused by NR5A1 mutationsYue Xu, Xuemeng Liu, Yang Liu, et al.
Neuro-Oncology|December 9, 2023
Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastomaYanfei Sun, Guangjing Mu, Xuehai Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 21, 2024
The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactionsZhiyi Xue, Yan Zhang, Ruiqi Zhao, et al.
Physical Review Letters|March 25, 2025
Establishing a New Benchmark in Quantum Computational Advantage with 105-qubit Zuchongzhi 3.0 ProcessorDongxin Gao, Daojin Fan, Chen Zha, et al.
Pageof 6